SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-154514
Filing Date
2022-05-19
Accepted
2022-05-19 07:57:31
Documents
14
Period of Report
2022-05-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d349205d8k.htm   iXBRL 8-K 51036
2 EX-10.1 d349205dex101.htm EX-10.1 79338
3 EX-10.2 d349205dex102.htm EX-10.2 30707
  Complete submission text file 0001193125-22-154514.txt   320038

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA epzm-20220517.xsd EX-101.SCH 2857
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20220517_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20220517_pre.xml EX-101.PRE 11262
8 EXTRACTED XBRL INSTANCE DOCUMENT d349205d8k_htm.xml XML 3336
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35945 | Film No.: 22941173
SIC: 2834 Pharmaceutical Preparations